Metropolitan Life Insurance CO Mei Pharma, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.42 - $0.65 $3,197 - $4,947	-7,612 Closed	0 $0
Q1 2022 Jun 20, 2023	BUY	$0.54 - $2.74 $4,110 - $20,856	7,612 New	7,612 $4,000
Q1 2022 Mar 30, 2023	BUY	$0.54 - $2.74 $397 - $2,016	736 Added 10.7%	7,612 $4,000
Q1 2022 May 12, 2022	BUY	$0.54 - $2.74 $397 - $2,016	736 Added 10.7%	7,612 $5,000
Q4 2021 Jun 21, 2023	BUY	$2.33 - $3.37 $16,021 - $23,172	6,876 New	6,876 $18,000
Q4 2021 Mar 30, 2023	SELL	$2.33 - $3.37 $24,012 - $34,731	-10,306 Reduced 59.98%	6,876 $18,000
Q4 2021 Feb 15, 2022	SELL	$2.33 - $3.37 $24,012 - $34,731	-10,306 Reduced 59.98%	6,876 $18,000
Q3 2021 Jun 21, 2023	BUY	$2.52 - $2.99 $43,298 - $51,374	17,182 New	17,182 $47,000
Q3 2021 Mar 30, 2023	SELL	$2.52 - $2.99 $22,858 - $27,122	-9,071 Reduced 34.55%	17,182 $47,000
Q3 2021 Nov 15, 2021	SELL	$2.52 - $2.99 $22,858 - $27,122	-9,071 Reduced 34.55%	17,182 $47,000
Q2 2021 Jun 21, 2023	BUY	$2.6 - $3.65 $68,257 - $95,823	26,253 New	26,253 $74,000
Q2 2021 Mar 30, 2023	BUY	$2.6 - $3.65 $26,449 - $37,131	10,173 Added 63.26%	26,253 $74,000
Q2 2021 Aug 16, 2021	BUY	$2.6 - $3.65 $68,216 - $95,765	26,237 Added 163981.25%	26,253 $75,000
Q1 2021 Jun 26, 2023	BUY	$2.73 - $4.5 $43,898 - $72,360	16,080 New	16,080 $55.2 Million
Q1 2021 Mar 30, 2023	SELL	$2.73 - $4.5 $39,781 - $65,574	-14,572 Reduced 47.54%	16,080 $55,000
Q1 2021 May 14, 2021	SELL	$2.73 - $4.5 $83,636 - $137,862	-30,636 Reduced 99.95%	16 $55,000
Q4 2020 Jun 22, 2023	BUY	$2.6 - $3.32 $79,695 - $101,764	30,652 New	30,652 $80,000
Q4 2020 Mar 30, 2023	BUY	$2.6 - $3.32 $967 - $1,235	372 Added 1.23%	30,652 $80,000
Q4 2020 Feb 16, 2021	BUY	$2.6 - $3.32 $967 - $1,235	372 Added 1.23%	30,652 $81,000
Q3 2020 Jun 26, 2023	BUY	$2.46 - $4.27 $74,488 - $129,295	30,280 New	30,280 $94,000
Q3 2020 Mar 30, 2023	SELL	$2.46 - $4.27 $9,234 - $16,029	-3,754 Reduced 11.03%	30,280 $94,000
Q3 2020 Nov 13, 2020	SELL	$2.46 - $4.27 $9,234 - $16,029	-3,754 Reduced 11.03%	30,280 $94,000
Q2 2020 Jun 26, 2023	BUY	$1.45 - $4.3 $49,349 - $146,346	34,034 New	34,034 $140,000
Q2 2020 Mar 30, 2023	BUY	$1.45 - $4.3 $49,349 - $146,346	34,034 New	34,034 $140,000
Q2 2020 Aug 14, 2020	BUY	$1.45 - $4.3 $49,349 - $146,346	34,034 New	34,034 $141,000

Others Institutions Holding MEIP

# of Institutions

Shares Held

Call Options Held

Put Options Held

Urban Wealth Management, LLC

2K
Shares

$5,777
0.0% of portfolio

View Full List

About MEI Pharma, Inc.

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $385M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

More about MEIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account